rss
JAMIA 2008;15:581-584 doi:10.1197/jamia.M2605
  • Perspectives on Informatics
  • Case Report

Opportunities for Electronic Health Record Data to Support Business Functions in the Pharmaceutical Industry—A Case Study from Pfizer, Inc.

  1. Daijin Kima,c,
  2. Steven Labkoffa,
  3. Samuel H Hollidayb,d
  1. aPfizer Healthcare Informatics, Pfizer Inc., New York, NY
  2. bAccenture, Philadelphia, PA
  3. cColumbia University, New York, NY
  4. dUniversity of Pennsylvania, Philadelphia, PA
  1. Correspondence: Daijin Kim, MBA, 235 East 42nd Street, New York, NY, 10017, Mailstop 235/14/9; e-mail: <daijin.kim{at}pfizer.com>
  • Received 22 August 2007
  • Accepted 6 June 2008

Abstract

The Pfizer Healthcare Informatics team conducted a series of guided interviews with 35 Pfizer senior leaders to elicit their understanding, desires, and expectations of how Electronic Health Records (EHR) might be used in the pharmaceutical industry today and/or in the future. The interviews yielded fourteen use case categories comprising 42 specific use cases. The highest priority use cases were “Drug Safety & Surveillance,” “Clinical Trial Recruitment,” and “Support Regulatory Approval.” Fifteen EHR companies were surveyed to assess their functionality against the specified use cases. Self-reported responses from the EHR companies were highest for “Virtual Phase IV Trials” and “Document Management for Clinical Trials.” This research identifies preliminary opportunities for EHR products to provide aggregate, blinded data to address the interests of the pharmaceutical industry. However, further collaboration between the stakeholders will be necessary to ensure the full realization of the opportunities for data re-use.

Footnotes

  • Funding for this research was provided by Pfizer Inc.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. Data Supplement

Responses

  1. Submit a response
  2. No responses published

Access policy for JAMIA

All content published in JAMIA is deposited with PubMedCentral by the publisher but with varying embargo times. Authors/funders may pay an Unlocked fee of $2,000 to make the article free on the JAMIA website and PMC immediately on publication. Research funded by government and other recognised agencies is deposited with a 12 month embargo. All other content is deposited with a 36 month embargo.

The Journal of the American Medical Informatics Association is published for the American Medical Informatics Association by BMJ Publishing Group Ltd.